Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 198
| Current Price | ₹108.37 |
|---|---|
| Market Cap | ₹225 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 301 |
| Return on Equity | 1.24% |
| 52-Week Range | ₹67.72 – ₹147.00 |
| Beta (1Y) | 0.21 |
| Dividend Yield | 0.00% |
1. Providing Health Care (Eye Care) Services-100%
Lotus Eye Hospital And Institute is trading at ₹108.37, with a market capitalisation of ₹225 Cr.
Lotus Eye Hospital And Institute operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Lotus Eye Hospital And Institute has a P/E of 301 and a return on equity of 1.24%.